Vitamin D may protect against colitis adverse events in patients taking immune checkpoint inhibitors
People with melanoma who take immune checkpoint inhibitors are less likely to develop colitis if they are taking vitamin D supplements at treatment initiation, a study published in the journal Cancer has suggested
Source: The Pharmaceutical Journal - Category: Drugs & Pharmacology Source Type: research
More News: Cancer | Cancer & Oncology | Drugs & Pharmacology | Melanoma | Skin Cancer | Study | Vitamin D | Vitamins